Patents by Inventor Luc L. Lebreton

Luc L. Lebreton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of 4-(hetero)arylmethyloxy phenyl diazole, a method of preparing them and use thereof in therapy
    Patent number: 5376648
    Abstract: Derivatives having the formula: ##STR1## in which R.sub.1 =C.sub.1 -C.sub.4 alkyl and Ar is an aryl or heteroaryl group chosen from among the following: ##STR2## where R.sub.2 represents a hydrogen atom one or two halogen atoms, a CN, NO.sub.2 or CF.sub.3 group, one, two or three C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy groups or an amino group substituted by two C.sub.1 -C.sub.4 alkyl groups, in which case the --W--V-- chain represents --N.dbd.N-- or ##STR3## and n=2-6; (ii) pyridyl, in which case the --W--V-- chain represents --N.dbd.N-- and n= 1-6, and acid addition salts of those derivatives (I) which are salt-forming.These derivatives are of use in therapy as agents for inhibiting type B monoamine oxydase.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: December 27, 1994
    Assignee: Delalande S.A.
    Inventors: Jean-Jacques Koenig, Luc L. Lebreton, Maryse F. Masson
  • Derivatives of 4-(hetero)arylmethyloxy phenyl diazole, a method of preparing them and use thereof in therapy
    Patent number: 5262432
    Abstract: Derivatives having the formula: ##STR1## in which R.sub.1 =C.sub.1 -C.sub.4 alkyl and Ar is an aryl or heteroaryl group chosen from among the following:(i) ##STR2## where R.sub.2 represents a hydrogen atom one or two halogen atoms, a CN, NO.sub.2 or CF.sub.3 group, one, two or three C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy groups or an amino group substituted by two C.sub.1 -C.sub.4 alkyl groups, in which case the --W--V-- chain represent ##STR3## and n=2-6; (ii) pyridyl, in which case the --W--V-- chain represents --N.dbd.N--and n=1-6, and acid addition salts of those derivatives (I) which are salt-forming.These derivatives are of use in therapy as agents for inhibiting type B monoamine oxydase.
    Type: Grant
    Filed: May 5, 1992
    Date of Patent: November 16, 1993
    Assignee: Delalande S.A.
    Inventors: Jean-Jacques Koenig, Luc L. Lebreton, Maryse F. Masson